Greenwich Stock Market Sentiment

GLSI
 Stock
  

USD 8.96  0.49  5.79%   

Greenwich investor sentiment overview provides quick insight into current market opportunities from investing in Greenwich Lifesciences. The current market sentiment together Greenwich Lifesciences' historical and current headlines can help investors to time the market. Many technical investors use Greenwich Lifesciences stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Please check Greenwich Lifesciences Hype Analysis, Greenwich Lifesciences Correlation and Greenwich Lifesciences Performance.
  
Refresh
Greenwich Lifesciences stock news, alerts, and headlines are usually related to their technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Greenwich daily returns and investor perception about the current pice of Greenwich Lifesciences as well as its diversification or hedging effects on your existing portfolios.

Greenwich Latest Sentiment Indicators

200 Day MA
22.86
Short Percent
0.11
Short Ratio
1.51
Shares Short Prior Month
347.5 K
50 Day MA
9.66
52 Week Low
6.82
Shares Short
367 K
over six months ago at www.equities.com         
Greenwich LifeSciences falls 0.31 percent to Close at 35.45 on October 22 - Equities.com
Equities News
over six months ago at www.equities.com         
Greenwich LifeSciences falls 2.96 percent to Close at 36.09 on October 20 - Equities.com
Equities News
over six months ago at www.equities.com         
Greenwich LifeSciences falls 2.13 percent for October 18 - Equities.com
Equities News
over six months ago at www.investorplace.com         
The Moonshot Investor The Insider Track Strategy - Investorplace.com
sbwire news
over six months ago at www.equities.com         
Greenwich LifeSciences falls 2.44 percent for October 6 - Equities.com
Equities News
over six months ago at www.equities.com         
Greenwich LifeSciences falls 4.77 percent in Light Trading on October 4 - Equities.com
Equities News
over six months ago at simplywall.st         
We Think Greenwich LifeSciences Can Afford To Drive Business Growth - Simply Wall St
Simply Wall St News at Macroaxis
over six months ago at www.equities.com         
Greenwich LifeSciences gains 0.49 percent to Close at .12 on September 29 - Equities.com
Equities News
over six months ago at www.marketscreener.com         
Greenwich LifeSciences to Partner with Susan G. Komen Race for the Cure Houston - Marketscreener.com
news
over six months ago at www.marketscreener.com         
Greenwich LifeSciences to Present at the Benzinga Healthcare Small Cap Conference - marketscreener.c...
news
over six months ago at www.equities.com         
Greenwich LifeSciences falls 8.33 percent on Strong Volume September 24 - Equities.com
Equities News
over six months ago at www.equities.com         
Greenwich LifeSciences gains 3.37 percent to Close at 45.16 on September 23 - Equities.com
Equities News
over six months ago at www.equities.com         
Greenwich LifeSciences falls 4.02 percent in Active Trading on September 15 - Equities.com
Equities News
over six months ago at www.equities.com         
Greenwich LifeSciences falls 1.21 percent for September 13 - Equities.com
Equities News
over six months ago at www.marketscreener.com         
Greenwich LifeSciences to Present at H.C. Wainwright 23rd Annual Global Investment Conference - mark...
news
There is far too much social signal, news, headlines, and media speculation about Greenwich Lifesciences that is available to investors today. That information is available publicly through Greenwich media outlets and privately through word of mouth or via Greenwich internal channels. However, regardless of the origin, that massive amount of Greenwich data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Greenwich Lifesciences news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Greenwich Lifesciences relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Greenwich Lifesciences' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Greenwich Lifesciences alpha.

Greenwich Lifesciences Performance against DOW

 Price Growth (%)  
      Timeline 
1
Purchase by Thompson Jaye of 500 shares of Greenwich Lifesci...04/20/2022
2
Purchase by Patel Snehal of 6000 shares of Greenwich Lifesci...04/21/2022
3
Purchase by Patel Snehal of 6000 shares of Greenwich Lifesci...04/22/2022
4
Purchase by Daugherty Frank Joseph of 1000 shares of Greenwi...04/26/2022
5
Insider Buying The Greenwich LifeSciences, Inc. CEO, CFO Dir...04/28/2022
6
Other05/16/2022
7
EPS Reported05/20/2022
8
Purchase by Patel Snehal of 6774 shares of Greenwich Lifesci...06/03/2022
9
Purchase by Patel Snehal of 9250 shares of Greenwich Lifesci...06/06/2022
10
Purchase by Patel Snehal of 6000 shares of Greenwich Lifesci...06/08/2022
11
Purchase by Patel Snehal of 4500 shares of Greenwich Lifesci...06/10/2022
12
Purchase by Patel Snehal of 12000 shares of Greenwich Lifesc...06/13/2022
13
Purchase by Patel Snehal of 12000 shares of Greenwich Lifesc...06/15/2022
14
Purchase by Patel Snehal of 8000 shares of Greenwich Lifesci...06/17/2022
15
Unclassified Event06/22/2022
16
Acquisition by Hallock Kenneth of 41349 shares of Greenwich ...06/24/2022
17
Purchase by Patel Snehal of 6465 shares of Greenwich Lifesci...06/27/2022
Please check Greenwich Lifesciences Hype Analysis, Greenwich Lifesciences Correlation and Greenwich Lifesciences Performance. Note that the Greenwich Lifesciences information on this page should be used as a complementary analysis to other Greenwich Lifesciences' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..

Complementary Tools for Greenwich Stock analysis

When running Greenwich Lifesciences price analysis, check to measure Greenwich Lifesciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Greenwich Lifesciences is operating at the current time. Most of Greenwich Lifesciences' value examination focuses on studying past and present price action to predict the probability of Greenwich Lifesciences' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Greenwich Lifesciences' price. Additionally, you may evaluate how the addition of Greenwich Lifesciences to your portfolios can decrease your overall portfolio volatility.
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Go
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Go
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Go
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Go
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Go
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Go
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Go
Is Greenwich Lifesciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Greenwich Lifesciences. If investors know Greenwich will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Greenwich Lifesciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
116.5 M
Return On Assets
-0.15
Return On Equity
-0.24
The market value of Greenwich Lifesciences is measured differently than its book value, which is the value of Greenwich that is recorded on the company's balance sheet. Investors also form their own opinion of Greenwich Lifesciences' value that differs from its market value or its book value, called intrinsic value, which is Greenwich Lifesciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Greenwich Lifesciences' market value can be influenced by many factors that don't directly affect Greenwich Lifesciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Greenwich Lifesciences' value and its price as these two are different measures arrived at by different means. Investors typically determine Greenwich Lifesciences value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Greenwich Lifesciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.